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Abstract	
	
Epidermal	homeostasis	depends	on	a	balance	between	stem	cell	renewal	and	differentiation	and	
is	regulated	by	extrinsic	signals	from	the	extracellular	matrix	(ECM)1,2.	A	powerful	approach	to	
analysing	the	pathways	involved	is	to	engineer	single-cell	microenvironments	in	which	individual	
variables	are	precisely	and	quantitatively	controlled3,4,5.	Here,	we	employ	micropatterned	
surfaces	to	identify	the	signalling	pathways	by	which	restricted	ECM	contact	triggers	human	
epidermal	stem	cells	to	initiate	terminal	differentiation.	On	small	(20	μm	diameter)	circular	
islands,	keratinocytes	remained	rounded,	and	differentiated	at	higher	frequency	than	cells	that	
could	spread	on	large	(50	μm	diameter)	islands.	Differentiation	did	not	depend	on	ECM	
composition	or	density.	Rather,	the	actin	cytoskeleton	mediated	shape-induced	differentiation	by	
regulating	serum	response	factor	(SRF)	transcriptional	activity.	Knockdown	of	SRF	or	its	co-factor	
MAL	inhibited	differentiation,	whereas	overexpression	of	MAL	stimulated	SRF	activity	and	
involucrin	expression.	SRF	target	genes	FOS	and	JUNB	were	also	required	for	differentiation:	c-Fos	
mediated	serum	responsiveness,	whereas	JunB	was	regulated	by	actin	and	MAL.	Our	findings	
demonstrate	how	biophysical	cues	are	transduced	into	transcriptional	responses	that	determine	
epidermal	cell	fate.	
	
Main	Text	
Human	interfollicular	epidermis	comprises	multiple	layers	of	keratinocytes.	Proliferation	takes	
place	in	the	basal	cell	layer,	attached	to	the	underlying	extracellular	matrix	known	as	the	
basement	membrane.	Cells	that	leave	the	basal	layer	undergo	a	programme	of	terminal	
differentiation	as	they	move	towards	the	tissue	surface.	Differentiated	cells	are	continually	shed	
from	the	epidermis	and	replaced	through	proliferation	of	stem	cells	in	the	basal	layer.	Several	
human	epidermal	stem	cell	markers	have	been	described,	including	elevated	levels	of	β1	(ref.	2)	
and	α6	(ref.	6)	integrins,	and	expression	of	Delta-like1	(Dll1;	ref.	7),	Lrig1	(ref.	8)	and	p63	(ref.	9).	
Terminal	differentiation	is	characterized	by	withdrawal	from	the	cell	cycle	and	expression	of	a	
number	of	proteins,	including	involucrin,	periplakin	and	transglutaminase	1,	which	subsequently	
become	incorporated	into	the	epidermal	cornified	envelope10,11.	
To	investigate	the	role	of	cell–ECM	interactions	in	regulating	the	differentiation	of	human	
epidermal	stem	cells,	micropatterned,	polymer	brush	substrates	were	developed	by	micro-contact	
printing	and	surface-initiated	polymerization12,13	(Fig.	1a).	We	constructed	circular	islands	(20–50	
μm	diameter)	composed	of	type	I	collagen,	surrounded	by	a	background	that	was	resistant	to	
protein	adsorption	(Fig.	1a,	b).	When	keratinocytes	were	seeded	onto	these	substrates,	cells	
adhered	specifically	to	the	collagen	islands	within	1	h	and	displayed	increasingly	spread	
morphologies	with	increasing	island	size	(Fig.	1b).	
The	adherent	cells	were	negative	for	involucrin	and	positive	for	Ki67	(Fig.	1c–e).	After	24	h,	the	
number	of	involucrin-positive	cells	increased	significantly	on	the	smallest	islands,	and	there	was	an	
inverse	correlation	between	the	number	of	differentiated	cells	and	adhesive	area	(Fig.	1c,	d	and	
Supplementary	Information,	Fig.	S1a,	b).	There	was	a	decrease	in	Ki67	expression	on	all	island	sizes	
after	24	h,	with	the	greatest	decrease	found	on	the	smallest	islands	(Fig.	1c,	e).	S	phase	cells	were	
not	present	on	20	μm	islands,	but	were	found	on	larger	islands	(Supplementary	Information,	Fig.	
S1c).	Blocking	DNA	synthesis	did	not	alter	the	effect	of	island	size	on	involucrin	expression	
(Supplementary	Information,	Fig.	S1d),	indicating	that	differentiation	is	regulated	independently	of	
cell-cycle	exit3,14.	These	results	demonstrate	that	engineered	substrates	can	modulate	the	
adhesive	interactions	of	single	human	keratinocytes	and	induce	terminal	differentiation	by	
restricting	adhesive	area.	
To	examine	whether	micropatterned	substrates	selectively	captured	stem	cells,	basal	cells	(low	
forward	scatter	and	side	scatter)	were	flow-sorted	according	to	surface	β1	integrin	expression2	
(Fig.	2a).	Keratinocytes	with	low	β1	integrin	expression	did	not	adhere	to	the	substrates	within	1	h,	
and	could	not	be	scored	for	differentiation.	The	effect	of	adhesive	area	on	involucrin	expression	
was	similar	in	unsorted,	low	forward	scatter/side	scatter,	and	high	β1	integrin-expressing	
populations	(Fig.	2b).	We	next	isolated	individual	cells	from	20	and	50	μm	diameter	islands	and	
performed	single-cell	RT–PCR	for	the	stem	cell	markers,	LRIG1	(ref.	8)	and	DLL1	(ref.	7).	On	20	μm	
islands,	the	proportion	of	LRIG1-	and	DLL1-positive	cells	decreased	from	approximately	50%	to	
20%	in	24	h	(Fig.	2c).	In	contrast,	the	number	of	LRIG1-	and	DLL1-positive	cells	on	50	μm	islands	
remained	constant	(Fig.	2c).	We	conclude	that	rapid	adhesion	to	micropatterned	substrates	
enriches	for	stem	cells	and	that	limited	adhesion	promotes	exit	from	the	stem-cell	compartment.	
The	proportion	of	cells	that	differentiated	on	each	island	size	was	not	significantly	different	when	
micropatterned	substrates	were	coated	with	collagen,	fibronectin	or	laminin	(Fig.	3a).	Similarly,	
island	size	regulated	involucrin	expression	independently	of	the	total	amount	of	adsorbed	collagen	
(Fig.	3b	and	Supplementary	Information,	Fig.	S2).	To	directly	examine	the	effect	of	cell	shape,	we	
generated	patterned	substrates	with	constant	elliptical	areas	(equivalent	to	circular	islands	with	
30	μm	diameters)	and	varying	shape	factors	(shape	factor	=	major	axis/minor	axis;	Fig.	3c).	After	
24	h,	there	were	significantly	fewer	involucrin-positive	cells	on	substrates	with	a	shape	factor	of	8,	
compared	with	a	shape	factor	of	1	(Fig.	3d).	Together,	these	results	demonstrate	that	cell	shape,	
rather	than	ECM	type	or	density,	is	the	key	determinant	of	keratinocyte	terminal	differentiation	
on	micropatterned	substrates.	
	
To	understand	how	cell	shape	regulates	differentiation,	we	first	examined	the	actin	cytoskeleton	
and	focal	adhesions.	On	the	largest	islands	(50	μm	diameter),	keratinocytes	formed	distinct	F-actin	
stress	fibres	at	the	basal	surface,	and	robust	focal	adhesions	containing	vinculin,	talin	and	paxillin	
(Fig.	3e;	talin	and	paxillin	data	not	shown).	On	small	islands	(20	μm	diameter),	cells	had	fewer	and	
smaller	focal	adhesions	and	the	F-actin	was	arranged	in	a	dense	cortical	shell	(Fig.	3e).	
Keratinocytes	on	50	μm	islands	displayed	strong	staining	for	monomeric	G-actin	and	cofilin	(an	F-
actin	severing	protein),	both	in	lamellipodia	and	the	cell	body	(Fig.	3f).	Quantification	of	phalloidin	
and	DNaseI	fluorescence	revealed	significantly	higher	levels	of	F-actin	and	lower	levels	of	G-actin	
on	20	μm	islands,	compared	with	50	μm	islands	(Fig.	3g	and	Supplementary	Information,	Fig.	S3).	
Higher	levels	of	F-actin	and	lower	G-actin	levels	were	also	observed	on	substrates	with	a	shape	
factor	of	1,	compared	with	substrates	with	a	shape	factor	of	8	(Supplementary	Information,	Fig.	
S3).	Previous	studies	have	indicated	that	actin	polymerization	increases	rapidly	during	the	initial	
stages	of	integrin-mediated	adhesion,	but	then	decreases	with	cell	spreading15.	Our	findings	
support	those	observations	and	suggest	that	restricted	spreading	impairs	actin	disassembly	and	
remodelling.	
To	assess	how	changes	in	cytoskeletal	organization	influence	keratinocyte	differentiation,	we	
employed	several	actin-disrupting	agents.	Treatment	with	latrunculin	A,	which	sequesters	free	
actin16,	resulted	in	reduced	F-actin	and	focal	adhesion	assembly	and	increased	G-actin	levels	on	
non-patterned	surfaces	(Fig.	3h).	The	Rho-kinase	(ROCK)	inhibitor,	Y27632,	also	inhibited	actin	
polymerization	and	focal	adhesion	assembly,	but	caused	an	increase	in	keratinocyte	spreading	
(Fig.	3h).	Treatment	with	these	inhibitors	blocked	involucrin	expression	on	20	μm	islands	(Fig.	3i).	
Treatment	with	blebbistatin,	which	inhibits	myosin	light	chain	kinase	(MLCK)	and	actin-myosin	
contractility,	slightly	inhibited	involucrin	expression	but	did	not	block	the	shape	effect	
(Supplementary	Information,	Fig.	S3g).	The	MEK	inhibitor	U0126	did	not	affect	differentiation	
(Supplementary	Information,	Fig.	S3h)	suggesting	that	although	MAPK	(mitogen-activated	protein	
kinase)	signalling	regulates	differentiation	downstream	of	β1	integrins17,	it	is	not	involved	in	
actin-regulated	differentiation.	
Cytochalasin	D,	which	blocks	actin	polymerization18,	disrupted	stress	fibre	formation,	reduced	
focal	adhesions	and	stimulated	differentiation	on	50	μm	islands	(Fig.	3h,	i).	Jasplakinolide,	which	
stabilizes	F-actin	filaments19,	caused	F-actin	aggregation,	loss	of	focal	adhesions	and	decreased	G-
actin	staining	(Fig.	3h).	Jasplakinolide	stimulated	differentiation	on	30	and	50	μm	islands	(Fig.	3i).	
Treatment	of	keratinocytes	on	50	μm	islands	with	Jasplakinolide	for	only	4	h	was	sufficient	to	
induce	involucrin	expression	at	24	h	(Supplementary	Information,	Fig.	S3f),	indicating	a	role	for	the	
actin	cytoskeleton	at	the	time	of	commitment	to	differentiation1.	
The	effects	of	the	actin-modulating	drugs	are	consistent	with	previously	reported	effects	on	SRF	
activity20,21,22.	SRF	is	a	transcription	factor	that	binds	to	'CArG'	DNA	sequences	and	regulates	
expression	of	adhesion-related	and	immediate–early	genes22,23.	SRF	interacts	with	the	co-factor,	
megakaryocytic	acute	leukaemia	(MAL;	also	known	as	MRTF-A	and	MKL1),	and	is	sensitive	to	
changes	in	G-actin	levels20,21.	Monomeric	G-actin	binds	to	MAL	and	prevents	it	from	binding	to	
SRF	and	activating	transcription.	Latrunculin	A	inhibits	SRF	activity	by	increasing	the	levels	of	G-
actin	and	sequestering	MAL	from	the	nucleus,	whereas	cytochalasin	D	disrupts	actin–MAL	
interactions	and	stimulates	SRF	activity20,21.	SRF	has	recently	been	shown	to	have	a	role	in	
murine	epidermal	homeostasis24.	
To	explore	the	function	of	SRF	signalling	in	shape-induced	differentiation,	we	first	examined	MAL	
localization.	On	small	islands,	where	spreading	was	restricted,	MAL	localized	to	the	cell	body	
surrounding	the	nucleus,	but	on	larger	islands	was	redistributed	to	the	basal	surface	and	the	
leading	edge	of	lamellipodia	(Fig.	4a),	similar	to	the	localization	of	G-actin	and	cofilin	(Fig.	3f).	MAL	
continuously	shuttles	between	the	cytoplasm	and	the	nucleus21,	and	although	differences	in	
nuclear	MAL	were	not	detected	on	micropatterned	substrates,	it	is	possible	that	the	increased	
proximity	of	MAL	to	the	nucleus	in	cells	on	20	μm	islands	influences	the	kinetics	of	this	process.	
Under	basal	and	serum-stimulated	conditions,	MAL	was	found	in	both	the	nucleus	and	cytoplasm	
of	keratinocytes	cultured	on	non-patterned	surfaces	(Fig.	4a).	Disruption	of	the	cytoskeleton	with	
latrunculin	A	excluded	MAL	from	the	nucleus,	whereas	cytochalasin	D	treatment	promoted	
accumulation	of	MAL	in	the	nucleus	(Fig.	4a).	
The	effects	of	fetal	bovine	serum	(FBS),	latrunculin	A	and	cytochalasin	D	on	MAL	localization	
correlated	with	SRF	transcriptional	activity.	Stimulation	of	keratinocytes	with	10%	FBS	modestly	
increased	(4×)	SRF	activity	in	dual	luciferase	assays,	but	this	response	was	blocked	by	latrunculin	A	
(Fig.	4b).	Cytochalasin	D	strongly	activated	SRF	activity	(20×),	with	or	without	FBS	(Fig.	4b).	
Stimulation	of	SRF	activity	by	cytochalasin	D	was	blocked	by	siRNA	depletion	of	MAL	or	SRF	(Fig.	
4c).	Conversely,	siRNA	depletion	of	cofilin	increased	actin	polymerization,	inhibited	cell	spreading	
and	stimulated	SRF	transcriptional	activity	on	non-patterned	surfaces	(Fig.	4d–f).	Thus,	cofilin-
mediated	actin	disassembly	is	required	for	efficient	cell	spreading,	and	impaired	spreading	
correlates	with	SRF	activation	in	keratinocytes.	
We	observed	a	synergistic	interaction	between	cell	shape	and	serum	on	micropatterned	
substrates	that	is	consistent	with	a	role	for	MAL/SRF	signalling	in	terminal	differentiation.	Addition	
of	10%	FBS	to	defined	medium	(keratinocyte	serum-free	medium)	potentiated	shape-induced	
involucrin	expression	(Fig.	4g).	BMP	2/7	(bone	morphogenetic	protein	2/7),	calcium	ions	and	
insulin	were	not	permissive	for	differentiation,	and	inhibition	of	epidermal	growth	factor	(EGF)	
receptor	signalling	had	no	effect	(Fig.	4g).	
To	directly	test	whether	MAL/SRF	signalling	regulates	differentiation,	we	reduced	MAL	and	SRF	
levels	in	keratinocytes	by	siRNA	transfection.	Twenty-four	hours	after	seeding	onto	
micropatterned	substrates,	cells	transfected	with	MAL	or	SRF	siRNA	exhibited	a	significant	
reduction	in	differentiation	on	20	μm	islands	(Fig.	4h).	MAL-	or	SRF-knockdown	in	cells	cultured	on	
non-patterned	surfaces	had	little	effect	on	LRIG1,	DLL1	or	ITGB1	expression	(Supplementary	
Information,	Fig.	S4e),	but	given	the	complexity	of	SRF	signalling25	and	the	heterogeneity	of	the	
target	population,	this	result	is	not	surprising.	Overexpression	of	Flag-tagged	MAL	increased	SRF	
activity	(20×)	and	involucrin	expression	(2×),	a	response	that	was	not	observed	when	cells	
expressed	a	form	of	MAL	lacking	the	SRF-binding	domain	(MAL	ΔB;	ref.	20;	Fig.	4i,	j).	Our	
experiments	indicate	that	MAL-dependent	activation	of	SRF	promotes	terminal	differentiation	of	
human	keratinocytes.	
Members	of	the	AP-1	family	of	transcription	factors,	FOS	and	JUNB,	are	known	SRF	target	
genes22,23	and	have	been	implicated	in	epidermal	terminal	differentiation26,27.	In	human	
keratinocytes,	FOS	mRNA	expression	was	transiently	upregulated	by	serum	stimulation	but	
unaffected	by	cytochalasin	D	treatment	(Fig.	5a),	whereas	JUNB	was	upregulated	in	cells	exposed	
to	serum	or	cytochalasin	D	(Fig.	5b).	SRF	knockdown	reduced	expression	of	both	FOS	and	JUNB,	
but	MAL	knockdown	only	inhibited	JUNB	(Fig.	5c).	To	confirm	that	JUNB	is	a	direct	target	of	
MAL/SRF	in	keratinocytes,	we	transfected	cells	with	Flag–MAL	or	Flag–MAL	ΔB	and	performed	
chromatin	immunoprecipitation	for	the	Flag	epitope	tag.	Enrichment	(8×)	for	a	serum	response	
element	(SRE)	approximately	1,500	kb	upstream	of	JUNB	was	detected	in	cells	expressing	wild-
type	MAL,	but	not	cells	expressing	the	MAL	ΔB	mutant	(Fig.	5d).	
There	were	more	JunB-positive	keratinocytes	on	20	μm	islands	than	on	50	μm	islands,	and	
latrunculin	A	treatment	blocked	this	difference	in	JunB	expression	(Fig.	5e,	f).	Exposure	to	the	AP-1	
inhibitor	Tanshinone	IIA	(TIIA)	or	specifically	reducing	c-Fos	or	JunB	levels	with	siRNA	significantly	
inhibited	involucrin	expression	on	20	μm	islands	(Fig.	5g,	h	and	Supplementary	Information,	Fig.	
S4c).	The	more	complete	inhibition	of	differentiation	by	c-Fos-	or	JunB-knockdown,	compared	with	
MAL-	or	SRF-knockdown,	may	reflect	MAL/SRF	independent	regulation	of	AP-1	signalling	or	
compensation	by	other	transcription	factors,	such	as	SAP-1a,	in	the	absence	of	SRF28.	We	
conclude	that	FOS	and	JUNB	are	SRF	target	genes	required	for	terminal	differentiation.	While	
serum	stimulates	FOS	expression,	G-actin	levels	and	MAL	regulate	JUNB	expression	(Fig.	5i).	
The	micropatterned	substrates	employed	in	these	studies	allowed	us	to	capture	individual	human	
epidermal	stem	cells	and	test	the	effects	of	systematically	altering	individual	parameters	of	the	
microenvironment.	We	have	demonstrated	that	cell	shape,	rather	than	adhesive	area,	ECM	
composition	or	ECM	density	controls	the	initiation	of	terminal	differentiation.	Our	data	suggest	
that	in	spread	cells	G-actin	inhibits	SRF	activity	by	limiting	the	availability	of	its	co-factor	MAL.	
When	cell	spreading	is	restricted,	the	level	of	G-actin	is	reduced,	SRF	activity	increases	and	JunB	
expression	is	stimulated.	Differentiation	also	depends	on	c-Fos,	which	is	upregulated	in	the	
presence	of	soluble	growth	factors.	We	speculate	that	the	requirement	for	two	distinct	
differentiation	stimuli	provides	a	fail-safe	mechanism	to	prevent	differentiation	occurring	if	a	lack	
of	growth	factors	prevents	the	stem	cell	pool	from	being	replenished	by	proliferation.	
The	pathway	we	have	identified	(Fig.	5i)	represents	a	new	mechanotransduction	mechanism	for	
regulating	epidermal	differentiation.	Different	cell	types	may	sense	the	same	biophysical	cues	
through	different	signalling	mechanisms.	Cell	shape	and	ROCK	regulate	differentiation	of	both	
epidermal	and	mesenchymal	stem	cells5,	but	whereas	cytoskeletal	tension	controls	mesenchymal	
stem	cell	differentiation,	G-actin	levels	are	the	key	sensor	in	keratinocytes.	Moreover,	LIM	kinases	
and	cofilin	activity	are	the	likely	downstream	targets	of	ROCK	responsible	for	regulating	actin	
polymerization	and	terminal	differentiation29,30.	
In	vivo,	actin	polymerization	and	SRF	activity	within	the	epidermis	could	be	stimulated	by	multiple	
signals,	including	soluble	factors	and	the	formation	of	adherens	junctions.	SRF	may	also	interact	
with	other	co-factors	and	activate	additional	target	genes,	such	as	integrins31	or	regulators	of	EGF	
signalling32.	Cell–matrix	interactions	may	be	particularly	important	in	the	case	of	wound	healing,	
where	keratinocyte	spreading	and	migration	into	a	wound	could	delay	terminal	differentiation	and	
allow	for	more	rapid	re-epithelialization33.	Our	findings	provide	a	mechanistic	explanation	for	why	
conditional	deletion	of	Srf	or	JunB	in	mouse	epidermis	results	in	hyperproliferation	and	impaired	
differentiation24,34	and	suggest	that	decreased	expression	of	SRF27,	JUNB24,34	and	LIMK1	(ref.	
30)	in	human	psoriasis	contribute	directly	to	disease	pathology.	
Our	studies	highlight	the	importance	of	defining	the	physical	parameters	of	the	stem	cell	niche.	
Engineered	microenvironments	are	valuable	tools	for	dissecting	how	extrinsic	stimuli	interact	with	
core	transcriptional	networks	to	control	cell	fate	decisions35,36.	
	
Methods	
Generation	of	micropatterned	polymer	brush	substrates.	
Patterned	polyoligo(ethylene	glycol	methacrylate)	(POEGMA)	brushes	were	generated	as	
previously	described12,13,37.	Briefly,	master	silicon	moulds	were	created	by	photolithography	
and	used	to	cast	poly-dimethylsiloxane	(PDMS)	stamps.	The	micropatterned	stamps	were	inked	
with	the	thiol	initiator,	ω-mercaptoundecyl	bromoisobutyrate,	and	brought	into	conformal	contact	
with	gold-coated	coverslips	to	deposit	the	initiator	as	a	self-assembled	monolayer.	Atom	transfer	
radical	polymerisation	(ATRP)	of	oligo(ethylene	glycol)	methacrylate	(OEGMA;	Mr	300)	was	carried	
out	in	a	water/ethanol	(4:1)	solution	of	OEGMA	(1.6	M),	Cu(II)Br2	(3.3	mM),	bipyridine	(82	mM)	
and	Cu(I)Cl	(33	mM).	The	reaction	was	performed	at	room	temperature	for	15	min,	resulting	in	an	
estimated	20	nm	thick	brush.	The	patterned	substrates	were	rinsed	with	water	and	ethanol,	dried,	
and	stored	under	N2.	
Unless	otherwise	stated,	patterned	substrates	were	coated	with	20	μg	ml−1	of	rat	type	I	collagen	
(BD	Biosciences)	in	PBS	for	1	h	at	37	°C.	Substrates	were	rinsed	three	times	with	1	mM	HCl	and	
twice	with	PBS.	For	the	collagen	density	studies,	solutions	with	1.6–20	μg	ml−1	collagen	were	
prepared	by	titrating	with	a	5	μg	ml−1	bovine	serum	albumin	(BSA)	solution.	To	test	different	ECM	
proteins,	substrates	were	coated	with	20	μg	ml−1	collagen,	20	μg	ml−1	human	fibronectin	(BD	
Biosciences)	or	20	μg	ml−1	human	placental	laminin	(Sigma	Aldrich).	For	both	the	ECM	type	and	
density	experiments,	FBS	in	the	culture	medium	was	depleted	of	fibronectin	by	passage	over	a	
gelatin–Sepharose	column	(GE	Healthcare).	
Culture	of	primary	human	keratinocytes.	
Primary	human	keratinocytes	were	isolated	from	neonatal	foreskin	and	maintained	on	a	feeder	
layer	of	J2	3T3	fibroblasts,	as	previously	described2,7,38.	Following	removal	of	the	feeder	layer,	
keratinocytes	(passage	2–8)	were	trypsinized	and	re-seeded	onto	the	micropatterned	substrates	
at	a	density	of	25,000	per	cm2	in	complete	FAD	medium	containing	1	part	Ham's	F12,	3	parts	
Dulbecco's	modified	eagle	medium,	10−4	M	adenine,	10%	FBS,	0.5	μg	ml−1	hydrocortisone,	5	μg	
ml−1	insulin,	10−10	M	cholera	toxin	and	10	ng	ml−1	EGF.	Cells	were	allowed	to	adhere	for	1	h	and	
then	rinsed	three	times	with	fresh	medium.	For	some	experiments,	inhibitor-supplemented	
medium	was	added	at	the	indicated	dose	immediately	after	rinsing.	Where	stated,	keratinocytes	
were	cultured	in	complete	keratinocyte	serum-free	medium	(KSFM;	Invitrogen).	
Antibodies	and	inhibitors.	
The	rabbit	anti-type	I	collagen	(1:200),	anti-Ki67	(1:1000),	anti-cofilin	(1:100),	anti-JunB	(1:100)	
and	anti-BrdU	(1:1000)	antibodies	were	purchased	from	Abcam.	Mouse	anti-involucrin	(SY5;	
1:500),	rabbit	anti-periplakin	(1:500),	mouse	anti-transglutaminase	I	(BC1;	1:500)	and	mouse	anti-
keratin14	(LL002;	1:500)	were	prepared	by	Cancer	Research	UK	central	services.	FITC-conjugated	
rat	anti-β1	integrin	(K20;	1:1000)	was	from	Dako.	Mouse	anti-vinculin	(Hvin1;	1:500),	mouse	anti-
Flag	(M2;	1:1000)	and	TRITC–phalloidin	(1:500)	were	from	Sigma	Aldrich.	Alexafluor488–DNaseI	
(1:500)	was	from	Invitrogen	and	mouse	anti-paxillin	(P13520;	1:200)	was	from	BD	Biosciences.	
The	ROCK	inhibitor	Y27632,	latrunculin	A,	Blebbistatin,	U0126	and	cytochalasin	D	were	obtained	
from	Calbiochem	(La	Jolla,	CA).	Jasplakinolide	was	from	Invitrogen	and	Tanshinone	IIA	was	from	
BIOMOL.	
Transfections,	siRNA	and	luciferase	assays.	
Keratinocytes	were	cultured	in	KSFM	on	collagen-coated	dishes	for	24	h	before	transfection.	Cells	
were	transfected	for	3	h	using	1	μl	Lipofectamine	2000	(Invitrogen)	and	1	μg	DNA	per	105	cells.	
The	Flag–MAL,	Flag–MAL	ΔB,	and	SRF	reporter	(p3DA.luc)	constructs	were	provided	by	R.	
Treisman	(CRUK,	London	Research	Institute)	and	have	been	described	previously20.	Thymidine	
kinase-driven	Renilla	was	used	as	an	internal	control	and	transfected	at	a	ratio	of	1:1	with	
p3DA.luc.	Following	DNA	transfection,	cells	were	rinsed	and	then	cultured	for	24–48	h	before	
treating	with	FBS	and	inhibitors	or	seeding	onto	substrates.	Luciferase	assays	were	carried	out	in	
24-well	plates	(n	=	4	wells);	cells	were	treated	for	7	h	with	FBS	and	the	indicated	doses	of	
inhibitors,	then	harvested	and	analysed	using	the	dual	luciferase	assay	(Promega).	
For	siRNA	transfection,	cells	were	treated	with	20	pmol	of	RNA	per	105	cells.	Non-targeting	MAL39	
and	SRF	siRNAs	were	from	Qiagen,	and	FOS,	JUNB	and	CFL1	siRNAs	were	from	Applied	Biosystems	
(Supplementary	Information,	Fig.	S4).	Following	transfection,	cells	were	rinsed	and	cultured	in	
KSFM	for	72	h	before	treatment	with	FBS	and	inhibitors,	or	seeding	onto	substrates.	Cells	co-
transfected	with	the	reporters	and	siRNA	were	cultured	for	72	h	before	treatment	and	luciferase	
assays.	For	cell	spreading	assays,	keratinocytes	were	re-plated	at	low	density	(5,000	per	cm2)	in	
KSFM	on	collagen-coated	coverslips	and	rinsed	and	fixed	with	4%	paraformaldehyde	after	1	h.	
Immunofluorescence	microscopy	staining	and	quantification.	
Cultured	cells	were	fixed	in	4%	paraformaldehyde	for	10	min	and	permeabilized	with	0.2%	Triton	
X-100	for	5	min	at	room	temperature.	Samples	were	blocked	for	1	h	in	10%	FBS	plus	0.25%	gelatin,	
incubated	with	primary	antibodies	for	1	h	at	room	temperature	or	overnight	at	4	°C,	and	
incubated	with	Alexafluor	(488	and	555)-conjugated	secondary	antibodies	(1:1000)	for	1	h	at	room	
temperature.	TRITC–phalloidin,	AF488–DNaseI,	and	DAPI	(4,6-diamidino-2-phenylindole)	were	
included	in	the	secondary	antibody	solution	where	indicated.	Fixed	and	stained	coverslips	were	
mounted	on	glass	slides	with	Mowiol	reagent,	and	images	were	acquired	with	a	Leica	DMI4000	
fluorescence	microscope	or	Leica	TCS	SP5	confocal	microscope.	
For	the	scoring	of	involucrin,	transglutaminase	1,	periplakin	and	JunB	expression,	at	least	six	
fluorescence	images	were	taken	per	condition	(approximately	50	cells)	per	experiment	and	
analysed	with	Image	J	software.	Cells	with	intensities	above	background	levels	(normal	mouse	
serum)	were	scored	as	positive.	For	F-actin	and	G-actin	quantification,	the	integrated	fluorescence	
of	phalloidin	and	DNaseI	z-stack	images	was	measured	for	individual	cells,	followed	by	subtraction	
of	the	background	fluorescence.	Cell	spreading	following	cofilin	knockdown	was	analysed	by	
staining	for	keratin	14	and	measuring	the	projected	area	per	cell	using	Image	J	software.	
Flow	cytometry.	
Freshly	trypsinized	keratinocytes	were	labelled	with	FITC-conjugated	anti-β1	integrin	antibody	in	
1%	BSA	for	45	min	at	4	°C.	Cells	were	rinsed	twice	and	non-viable	cells	were	labelled	with	7AAD	(7-
aminoactinomycin	D).	Cells	were	flow	sorted	with	a	MoFlo	high	speed	sorter	(Dako).	After	
selecting	only	viable	cells	with	low	forward	scatter	and	side	scatter,	cells	were	further	separated	
into	populations	with	the	highest	20%	or	lowest	20%	of	β1	integrin	expression.	Unsorted	cells	
were	held	in	suspension	while	sorting	was	underway.	All	groups	of	cells	were	then	re-suspended	in	
FAD	medium	and	seeded	onto	micropatterned	substrates.	
Chromatin	immunoprecipitation.	
Keratinocytes	(107)	were	transfected	with	Flag–MAL	or	Flag–MAL	ΔB,	cultured	overnight	in	KSFM,	
treated	with	10%	FBS	for	1	h,	and	fixed	with	1%	paraformaldehyde	for	10	min.	Chromatin	was	
sonicated	to	an	average	length	of	1	kb,	incubated	overnight	with	5	μg	anti-Flag	or	anti-HA	
antibodies	at	4	°C,	and	precipitated	with	G-protein	coupled	Dynabeads	(Invitrogen)	for	4	h	at	4	°C.	
Cross-links	were	reversed	by	incubating	at	65	°C	overnight,	and	DNA	was	isolated	with	a	PCR	
purification	kit	(Qiagen).	Quantitative	RT–PCR	was	performed	with	Sybr	green	(Sigma)	and	custom	
primers	for	regions	around	JUNB.	Data	are	reported	as	the	fold	enrichment	between	Flag	and	HA	
compared	to	the	centromeric	region	of	chromosome	11.	Primers	were	as	follows:	region	1:	
forward;	5ʹ-	CCTCTTCCTGTGCCCTAATATG-3ʹ,	reverse;	5ʹ-	CTTGGGGAGTGTTCCATTG-3ʹ;	region	2:	
forward;	5ʹ-	GATCCGAGTGACGGAGACAG-3ʹ,	reverse;	5ʹ-	CCCACTCCCTTCCTTAGAAAC-3ʹ;	region	3:	
forward;	5ʹ-	GCCGCTGTTTACAAGGACAC-3ʹ,	reverse;	5ʹ-	CTGAGCCACACGCCTTTATAC-3ʹ;	region	4:	
forward;	5ʹ-	AGGGACCCAGGAGCTGAAG-3ʹ,	reverse;	5ʹ-	GGCAGAATCGGTCCTTGTATG	and	Cen11:	
forward:	5ʹ-	GGCGACCAATAGCCAAAAAGTGAG,	reverse;	5ʹ-	CAATTATCCCTTCGGGGAATCGG-3ʹ.	
Single-cell	and	quantitative	RT–PCR.	
Single	keratinocytes	were	picked	from	the	micropatterned	substrates	and	pipetted	directly	into	
lysis	buffer.	Single-cell	RT–PCR	was	performed	as	previously	described8.	K14	and	GAPDH	double-
positive	reactions	were	scored	for	LRIG1	and	DLL1	expression.	Total	RNA	was	isolated	using	the	
Purelink	RNA	kit	(Invitrogen)	and	reverse	transcribed	to	cDNA	using	the	Superscript	III	kit	
(Invitrogen).	PCR	reactions	were	carried	out	with	Taqman	Gene	Expression	Assays	for	FOS,	JUNB,	
SRF,	MAL,	LRIG1,	DLL1,	ITGB1,	and	GAPDH	(Applied	Biosystems),	and	all	data	were	normalized	to	
GAPDH	expression.	
Statistical	Analyses.	
All	data	were	analysed	by	one-	or	two-factor	ANOVA	and	Tukey's	test	for	posthoc	analysis.	A	
logarithmic	transformation	was	used	to	normalize	the	relative	luciferase	activity	data	before	
statistical	analysis.	Significance	was	determined	by	P	<	0.05.	
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Figure	1:	Regulation	of	keratinocyte	shape	and	differentiation	on	micropatterned	substrates.	
(a)	Overview	of	the	micropatterning	strategy.	(b)	Immunofluorescence	microscopy	images	of	type	
I	collagen	(top)	and	phase-contrast	microscopy	images	of	primary	human	keratinocytes	(bottom)	
on	20,	30	and	50	μm	diameter	islands.	(c)	Representative	immunofluorescence	microscopy	images	
of	involucrin	and	Ki67	expression	on	substrates	with	20,	30	or	50	μm	diameters	at	1	h	and	24	h	
after	seeding.	Scale	bars,	100	μm.	(d)	Quantification	of	involucrin-positive	cells	at	1	h	and	24	h	on	
substrates	with	adhesive	areas	ranging	from	314	μm2	to	1963	μm2	(20–50	μm	diameters).	Data	
represent	means	±	s.e.m.	(n	=	4	experiments,	asterisk	indicates	P	=	0.0001,	compared	with	the	
cells	on	substrates	consisting	of	50	μm	diameter	islands).	(e)	Quantification	of	Ki67-positive	cells	at	
1	h	and	24	h.	Data	represent	means	±	s.e.m.	(n	=	4	experiments;	asterisk	indicates	P	=	0.0472,	
compared	with	the	cells	on	substrates	consisting	of	50	μm	diameter	islands).	
	
	
 
	
Figure	2:	Limited	adhesion	promotes	loss	of	stem	cell	markers.	
(a)	Flow	cytometry	plots	for	side	scatter	(SS)	versus	forward	scatter	(FS)	and	fluorescence	intensity	
of	the	PE	(phycoerythrin)	channel	versus	FITC	(fluorescein	isothiocyanate)	channel	for	negative-	
(non-labelled)	and	β1	integrin-labelled	cells.	R1:	gating	for	low	FS/SS	cells;	R2:	gating	for	cells	with	
highest	20%	of	β1	integrin	expression;	R3:	gating	for	cells	with	lowest	20%	of	β1	integrin	
expression.	(b)	Quantification	of	involucrin	expression	by	unsorted,	low	FS/SS	and	high	β1	integrin-
expressing	cells	24	h	after	adhesion	to	patterned	substrates.	(c)	Quantification	of	LRIG1	and	DLL1	
expressing	cells	at	1	h	and	24	h	on	patterned	substrates	using	single-cell	RT–PCR.	Data	represent	
means	±	s.e.m.	(n	=	3	experiments,	asterisk	indicates	P	=	0.0459,	compared	with	the	cells	on	
substrates	consisting	of	50	μm	diameter	islands).	
	
	
 
	
Figure	3:	The	actin	cytoskeleton	mediates	shape-induced	terminal	differentiation.	
(a,	b)	Quantification	of	involucrin	expression	after	24	h	on	substrates	coated	with	type	I	collagen,	
fibronectin	or	laminin	(a)	and	a	high	or	low	amount	of	total	collagen	(b;	also	see	Supplementary	
Information,	Fig.	S2).	Data	represent	means	±	s.e.m.	(n	=	4	experiments).	(c)	Representative	phase-
contrast	microscopy	images	of	keratinocytes	on	islands	with	shape	factors	of	1,	2,	4	and	8.	(d)	
Quantification	of	involucrin	expression	after	24	h	on	substrates	with	shape	factors	of	1–8.	Data	
represent	means	±	s.e.m.	(n	=	4	experiments;	asterisk	indicates	P	=	0.018,	compared	with	cells	on	
substrates	with	a	shape	factor	of	1).	Schematic	representation	indicates	how	shape	factor	(SF)	is	
calculated.	(e)	Immunofluorescence	microscopy	images	of	vinculin	and	F-actin	on	50	μm	and	20	
μm	islands.	Confocal	microscopy	images	show	basal	surface	(left)	and	z-stack	projection	(right).	(f)	
Confocal	microscopy	images	of	DNaseI-labelled	G-actin	and	immunostained	cofilin	on	20	μm	or	50	
μm	islands.	(g)	Quantification	of	F-	and	G-actin	levels	4	h	after	seeding	on	20	μm	or	50	μm	islands.	
Total	integrated	fluorescence	of	phalloidin	and	DNaseI	was	normalized	to	the	fluorescence	of	cells	
on	20	μm	islands.	Data	represent	means	±	s.e.m.	(n	=	3	experiments;	asterisk	indicates	P	=	0.0003	
for	F-actin	and	P	=	0.0165	for	G-actin,	compared	with	20	μm).	(h)	Immunofluorescence	microscopy	
images	of	focal	adhesions	(paxillin),	F-actin	and	G-actin	after	4	h	treatment	with	carrier	(0.1%	
DMSO),	0.4	μM	latrunculin	A	(Lat	A),	10	μM	Y27632,	1	μM	cytochalasin	D	(Cyto	D)	or	0.2	μM	
Jasplakinolide	(Jasp).	(i)	Quantification	of	involucrin	expression	after	24	h	on	substrates	with	
inhibitor	treatment.	Data	represent	means	±	s.e.m.	(n	=	3	experiments;	asterisk	indicates	P	=	0.022	
for	latrunculin	A	on	20	μm,	P	=	0.0072	for	Y27632	on	20	μm,	P	=	0.0054	for	Jasplakinolide	on	30	
μm,	P	=	0.0003	for	cytochalasin	D	on	50	μm	and	P	=	0.0001	for	Jasplakinolide	on	50	μm,	compared	
with	carrier	control).	Scale	bars,	25	μm.	
	
	
 
	
Figure	4:	Influence	of	MAL/SRF	signalling	on	shape-induced	differentiation.	
(a)	Flag–MAL	localization	on	patterned	substrates	(top).	Confocal	microscopy	images	show	basal	
surface	(left)	and	z-stack	projection	(right).	Flag–MAL	localization	on	non-patterned	surfaces	
treated	with	10%	FBS,	carrier	(0.1%	DMSO),	0.8	μM	latrunculin	A	(Lat	A)	or	1	μM	cytochalasin	D	
(Cyto	D).	Scale	bars,	20μm.	(b)	Firefly	luciferase	activity	relative	to	Renilla	in	keratinocytes	
expressing	the	SRF	reporter	(p3DA.luc)	and	treated	with	carrier,	0.8	μM	latrunculin	A	or	1	μM	
cytochalasin	D	±	10%	FBS.	Data	represent	means	±	s.e.m.	(n	=	3	experiments;	asterisk	indicates	P	=	
0.042	for	carrier	+	FBS,	compared	with	carrier	–FBS;	double	asterisks	indicate	P	=	0.0366	for	
latrunculin	A	and	P	=	0.0001	for	cytochalasin	D,	compared	with	carrier).	(c)	SRF	activity	in	
keratinocytes	co-transfected	with	non-targeting	(NT),	MAL	or	SRF	siRNA,	with	or	without	
cytochalasin	D.	Data	represent	means	±	s.e.m.	(n	=	3	experiments;	asterisks	indicate	P	=	0.0057	for	
MAL	siRNA-	and	P	=	0.0001	for	SRF	siRNA-treated	cells,	compared	with	cells	treated	with	NT	siRNA	
and	cytochalasin	D;	double	asterisks	indicate	P	=	0.0014	for	SRF	siRNA-treated	cells	compared	with	
NT	–	CytoD-treated	cells).	(d)	Distribution	of	F-actin	and	keratin	14	(K14)	following	treatment	with	
NT	siRNA	or	two	different	types	of	CFL1	(cofilin1)	siRNA	and	1	h	after	re-plating	on	non-patterned	
surfaces.	Scale	bars,	50μm.	(e)	Quantification	of	cell	spreading	at	1	h.	Data	represent	mean	areas	
per	cell	±	s.e.m.	(n	>	100	cells	from	a	representative	experiment;	asterisk	indicates	P	=	0.0001	for	
CFL1	siRNA	1	and	P	=	0.0001	for	CFL1	siRNA	2,	compared	with	NT).	(f)	Relative	SRF	activity	
following	siRNA	knockdown	and	7	h	treatment	with	10%	FBS.	Data	represent	means	±	s.e.m.	(n	=	3	
experiments;	asterisks	indicate	P	=	0.0215	for	CFL1	siRNA	2,	compared	with	NT).	(g)	Quantification	
of	involucrin	expression	after	24	h	on	20,	30	or	50	μm	diameter	islands	cultured	in	keratinocyte	
serum-free	medium	(KSFM)	supplemented	with	10	nM	AG1478	(EGF	inhibitor),	200	ng	ml−1	BMP	
2/7,	1.8	mM	CaCl2,	5	μg	ml−1	insulin	or	10%	FBS.	Data	represent	means	±	s.e.m.	(n	=	3	
experiments;	asterisk	indicates	P	=	0.0001	for	cells	cultured	in	FBS	on	20	μm	islands,	compared	
with	cells	cultured	under	the	same	conditions	on	50	μm	islands).	(h)	Quantification	of	involucrin	
expression	in	NT,	MAL	or	SRF	siRNA-treated	cells	after	24	h	on	micropatterned	substrates.	Data	
represent	means	±	s.e.m.	(n	=	5	experiments;	asterisks	indicate	P	=	0.037	for	MAL	siRNA-	and	P	=	
0.036	for	SRF	siRNA-treated	cells,	compared	with	NT	siRNA-treated	cells).	(i)	Involucrin	expression	
(red)	in	GFP	(green	fluorescent	protein)-,	Flag–MAL-,	or	Flag–MAL	ΔB-	(green)	expressing	cells	
after	48	h	on	non-patterned	surfaces.	Scale	bars,	50μm.	(j)	SRF	activity	and	percentage	of	
involucrin-positive	cells.	Data	represent	means	±	s.e.m.	(n	=	3	experiments;	asterisks	indicate	P	=	
0.0001	for	MAL	SRF	activity,	P	=	0.0008	for	MAL	involucrin,	compared	with	GFP-expressing	cells).	
	
	
 
	
Figure	5:	Regulation	of	AP-1	signalling	and	role	in	differentiation.	
(a)	FOS	and	(b)	JUNB	mRNA	expression	(relative	to	GADPH	expression)	measured	by	quantitative	
RT–PCR.	Keratinocytes	were	treated	with	10%	FBS	or	1	μM	cytochalasin	D	on	non-patterned	
surfaces	for	1,	4	or	24	h.	Data	represent	means	±	s.e.m.	(n	=	3	experiments;	asterisk	indicates	P	=	
0.0001	for	FOS	expression,	P	=	0.0003	for	JUNB	expression	in	FBS-treated	cells,	compared	with	
carrier-treated	cells;	double	asterisk	indicates	P	=	0.0185	for	JUNB	expression,	in	Cytochalasin	D-
treated	cells,	compared	with	carrier-treated	cells).	(c)	FOS	and	JUNB	mRNA	levels	following	1	h	
serum	stimulation	of	cells	transfected	72	h	previously	with	non-targeting	(NT),	SRF	or	MAL	siRNA.	
All	data	represent	means	±	s.e.m.	(n	=	3	experiments;	asterisk	indicates	P	=	0.0147	for	FOS	
expression,	P	=	0.0001	for	JUNB	expression	in	SRF	siRNA-treated	cells,	compared	with	NT	siRNA-
treated	cells:,	double	asterisk	indicates	P	=	0.0003	for	JUNB	expression	in	MAL	siRNA	treated-cells,	
compared	with	NT-treated	cells).	(d)	ChIP	(chromatin	immunoprecipitation)	serum	response	
elements	(SRE).	Schematic	representation	of	JUNB	and	primer	sites	1–4.	Bottom	panel	indicates	
quantification	of	enrichment	for	sites	1–4	with	anti-Flag	relative	to	anti-HA	(haemagglutinin)	in	
cells	expressing	Flag–MAL	or	Flag–MAL	ΔB.	Data	are	expressed	relative	to	the	centromeric	region	
of	chromosome	11	and	represent	means	±	s.e.m.	(n	=	3	experiments).	(e,	f)	Representative	images	
(e)	and	quantification	(f)	of	JunB-positive	cells	4	h	after	seeding	onto	20	μm	or	50	μm	substrates	
and	treatment	with	latrunculin	A.	Scale	bars,	50μm.	Data	represent	means	±	s.e.m.	(n	=	3	
experiments;	asterisk	indicates	P	=	0.0031,	compared	with	50	μm).	(g)	Quantification	of	involucrin	
expression	on	20	μm	and	50	μm	substrates	following	24	h	treatment	with	carrier	(0.1%	DMSO)	or	
1	μg	ml−1	tanshinone	IIA	(TIIA).	Data	represent	means	±	s.e.m.	(n	=	3	experiments;	asterisk	
indicates	P	=	0.0055,	compared	with	carrier).	(h)	Quantification	of	involucrin	expression	in	NT,	c-
Fos,	and	JunB	siRNA-treated	keratinocytes	24	h	after	seeding	onto	micropatterned	substrates.	
Data	represent	means	±	s.e.m.	(n	=	3	experiments;	asterisk	indicates	P	=	0.0007	for	c-Fos,	P	=	
0.0009	for	JUNB,	compared	with	NT	siRNA-treated	cells).	(i)	A	model	for	how	cell	shape	and	
growth	factors	regulate	keratinocyte	terminal	differentiation	through	SRF/MAL	and	AP1	signalling.	
GF;	growth	factor.	
	
	
	
